LIGAND UK DEVELOPMENT LIMITED
Get an alert when LIGAND UK DEVELOPMENT LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-30
Confirmation statement due
2026-10-14 (in 5mo)
Last made up 2025-09-30
Watchouts
None on the register
Cash
—
Latest balance sheet
Net assets
£17M
+385.5% vs 2023
Employees
—
Average over period
Profit before tax
£15M
+402.4% vs 2023
Name history
Renamed 3 times since incorporation
- LIGAND UK DEVELOPMENT LIMITED 2020-12-03 → present
- VERNALIS DEVELOPMENT LIMITED 2003-10-01 → 2020-12-03
- VERNALIS LIMITED 2000-05-19 → 2003-10-01
- VANGUARD MEDICA LIMITED 1991-04-11 → 2000-05-19
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-30
| Metric | Trend | 2023-12-30 | 2024-12-30 |
|---|---|---|---|
| Turnover | £20,000 | £15,596,000 | |
| Operating profit | -£4,936,000 | £14,926,000 | |
| Profit before tax | -£4,936,000 | £14,926,000 | |
| Net profit | -£4,936,000 | £13,461,000 | |
| Cash | — | — | |
| Total assets less current liabilities | £3,492,000 | £16,953,000 | |
| Net assets | £3,492,000 | £16,953,000 | |
| Equity | £3,492,000 | £16,953,000 | |
| Average employees | — | — | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-30 | 2024-12-30 |
|---|---|---|---|
| Operating margin | -24680.0% | 95.7% | |
| Net margin | -24680.0% | 86.3% | |
| Return on capital employed | -141.4% | 88.0% | |
| Current ratio | 1.81x | 4.28x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Grant Thornton UK LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The financial statements of the company have been prepared on a going concern basis which is dependent on the continuing financial support from its ultimate parent company, Ligand Pharmaceuticals Incorporated, which had adequate cash reserves to support the company for at least 12 months from the date these financials have been approved by the directors. The directors expect the Ligand group to continue in operation for the foreseeable future. The company therefore adopts the going concern basis in preparing the financial statements.”
Significant events
- “There are no significant post balance sheet events to disclose.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 51 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| VISTRA COSEC LIMITED | Corporate Secretary | 2024-04-04 | — | — |
| DAVIS, Todd Christopher | Director | 2022-12-05 | Dec 1960 | American |
| ESPINOZA, Octavio | Director | 2022-11-01 | Aug 1970 | American |
| REARDON, Andrew Thomas | Director | 2022-11-01 | Oct 1974 | American |
Show 51 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ANGGARD, Erik, Professor | Secretary | 1991-07-17 | 1993-01-15 |
| BERKMAN, Charles Stuart | Secretary | 2019-04-01 | 2022-11-01 |
| BOND, Jonathan Charles Howard | Secretary | 2003-09-04 | 2004-06-30 |
| HOOD, Alison Mary | Secretary | 2009-09-30 | 2010-11-30 |
| KARLIN, Fiona Elizabeth Joy | Secretary | 1993-01-15 | 1994-08-05 |
| KISSANE, Kevin Patrick | Secretary | 2010-11-30 | 2017-11-01 |
| MACKNEY, David | Secretary | 2017-11-01 | 2018-01-25 |
| ROBINSKI, Richard | Secretary | 2000-01-11 | 2003-02-28 |
| SLATER, John Andrew Duncan | Secretary | 2004-10-29 | 2009-09-30 |
| WALLCRAFT, Susan Jean | Secretary | 2018-01-25 | 2019-03-31 |
| WAYNE, Harold | Nominee Secretary | 1991-04-11 | 1993-04-11 |
| WORRALL, Peter Brian | Secretary | 2004-06-30 | 2004-10-29 |
| WORRALL, Peter Brian | Secretary | 2003-02-28 | 2003-09-04 |
| WORRALL, Peter Bryan | Secretary | 1994-08-05 | 2000-01-11 |
| DYE & DURHAM SECRETARIAL LIMITED | Corporate Secretary | 2021-05-04 | 2023-06-02 |
| ACTON, Gary, Doctor | Director | 1997-01-09 | 2000-04-06 |
| ANGGARD, Erik, Professor | Director | 1991-07-17 | 1993-04-15 |
| ASSCHER, Adolf William | Director | 1996-02-15 | 1998-09-02 |
| BENJAMIN, Jerry Christopher | Director | 1993-04-15 | 1996-05-09 |
| BERKMAN, Charles Stuart | Director | 2018-10-12 | 2022-11-01 |
| BICK, Peter, Dr | Director | 1993-04-15 | 1994-06-17 |
| BRIMBLECOMBE, Roger William, Dr | Director | — | 2000-05-19 |
| BRUCE, Andrew Richard | Director | 2000-12-18 | 2001-05-11 |
| CARTMELL, Simon Christopher | Director | 1998-10-26 | 2000-07-12 |
| CLARK, Michael | Director | 1991-12-23 | 1993-04-15 |
| CURNOCK COOK, Jeremy Lawrence | Director | 1993-04-15 | 1998-09-02 |
| DOURISH, Colin Trevor, Dr | Director | 2000-02-14 | 2004-02-20 |
| DUNCAN, William Alexander Mcintosh | Director | — | 1998-09-02 |
| FELLNER, Peter John, Dr | Director | 2008-11-14 | 2018-10-12 |
| FOEHR, Matthew William | Director | 2018-10-12 | 2022-11-01 |
| GARLAND, Ian | Director | 2009-06-15 | 2018-10-12 |
| HEIGHTMAN, Nicholas John | Director | 1996-03-01 | 2001-06-29 |
| HUTCHISON, John Blundell, Dr | Director | 2000-02-14 | 2007-08-31 |
| JACK, David, Sir | Director | 1991-07-25 | 1993-03-15 |
| JAFFE, Marvin Eugene | Director | 1998-03-11 | 1998-09-02 |
| JORDAN, Christine | Director | 2000-03-13 | 2000-10-13 |
| KORENBERG, Matthew Edward | Director | 2018-10-12 | 2024-10-15 |
| LAMOTTE, Andre L, Dr | Director | 1991-12-16 | 1998-05-14 |
| MACKNEY, David | Director | 2009-06-15 | 2018-10-12 |
| MANSFIELD, Robert | Director | 1992-10-26 | 2003-03-20 |
| NEEDHAM, David Alan, Dr | Director | 1994-06-17 | 1996-05-09 |
| READ, Peter Robert, Dr | Director | 1998-03-11 | 1998-09-02 |
| ROBINSKI, Richard | Director | 2000-02-24 | 2003-02-28 |
| SLATER, John Andrew Duncan | Director | 2008-04-20 | 2009-09-30 |
| SMITH SNR, Charles Giles, Dr | Director | — | 1996-02-15 |
| STURGE, Simon | Director | 2004-08-25 | 2008-02-29 |
| VANE, John Robert, Sir | Director | 1991-07-17 | 1998-05-14 |
| WATERMAN, Sally Christina, Dr | Director | 1998-10-30 | 2000-07-12 |
| WAYNE, Yvonne | Nominee Director | 1991-04-11 | 1993-04-11 |
| WEIR, Anthony John | Director | 2003-09-04 | 2008-11-14 |
| WORRALL, Peter Brian | Director | 1997-02-28 | 2004-10-29 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Ligand Holdings Uk Ltd. | Corporate entity | Shares 75–100% | 2023-09-21 | Active |
| Ligand Uk Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2023-09-21 |
Filing timeline
Last 20 of 312 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-10-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-10-04 | AA | accounts | Accounts with accounts type full | |
| 2025-04-15 | AA | accounts | Accounts with accounts type full | |
| 2025-04-08 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-05-23 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-04-10 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-04-10 | AP04 | officers | Appoint corporate secretary company with name date | |
| 2024-02-01 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-01-14 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2024-01-14 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2024-01-09 | AA | accounts | Accounts with accounts type full | |
| 2023-12-23 | DISS40 | gazette | Gazette filings brought up to date | |
| 2023-12-19 | GAZ1 | gazette | Gazette notice compulsory | |
| 2023-09-29 | AA01 | accounts | Change account reference date company previous shortened | |
| 2023-09-24 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-24 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-24 | AP01 | officers | Appoint person director company with name date | |
| 2023-09-24 | TM01 | officers | Termination director company with name termination date | |
| 2023-09-24 | TM01 | officers | Termination director company with name termination date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-30 vs 2023-12-30
-
Turnover
+77,880%
£20,000 £15,596,000
-
Cash
—
Not reported
-
Net assets
+385.5%
£3,492,000 £16,953,000
-
Employees
—
Not reported
-
Operating profit
+402.4%
-£4,936,000 £14,926,000
-
Profit before tax
+402.4%
-£4,936,000 £14,926,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers